Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
P&G to acquire German Merck's consumer health business for about $4.21 billion
Procter & Gamble has agreed to acquire Merck KGaA's consumer health unit for 3.
Allergan's Interest Raises Stakes in Pursuit of Drugmaker Shire
Allergan Plc’s potential offer for Shire Plc may start a bidding war with Takeda Pharmaceutical Co.
Rigel Announces FDA Approval of TAVALISSE™ (fostamatinib disodium hexahydrate) for Chronic Immune Thrombocytopenia (ITP) in Adult Patients
SOUTH SAN FRANCISCO, Calif.
FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia
The U.
Gates backs gene technologies in fight to end malaria
LONDON, April 18 (Reuters) - Gene-editing technologies that alter mosquitoes’ DNA could prove critical in the fight against malaria, Bill Gates said on Wednesday, and ethical concerns should...
Advent International enters into exclusive negotiations to acquire Zentiva, Sanofi’s European generics business
PARIS – 17 April 2018 – Advent International (“Advent”) and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi’s European generics busin...
World Hemophilia Day 2018: Sharing Knowledge Makes Us Stronger
On April 17, 2018, the global bleeding disorders community and the World Federation of Hemophilia (WFH) will come together to promote and encourage Sharing Knowledge and the role it plays i...
Karyopharm’s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Penta-Refractory Multiple Myeloma
NEWTON, Mass.
vTv Therapeutics Announces Topline Results from the First STEADFAST Phase 3 Study Evaluating Azeliragon in People with Mild Alzheimer’s Disease
HIGH POINT, N.
Mylan seeks deal for German Merck's consumer products unit: sources
FRANKFURT/NEW YORK (Reuters) - Generic drug maker Mylan NV is in advanced discussions to acquire Merck KGaA’s consumer health business after other bidders failed to meet the German company...
Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles
LONDON (Reuters) - Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its oncology business to unlisted Frenc...
Hanmi Pharma gives up on development of lung cancer drug Olita
South Korean pharmaceutical firm Hanmi Pharmaceutical is expected to cease development of Olita, a lung cancer treatment, following its slow progress in clinical trials and cancellation of licensing d...
484
485
486
487
488
489
490
491
492
